// App-Quantinova.ai

BSH2020‐PO‐101 : Exploiting VDJ recombination of T cells to dissect the anti‐cancer immune interactions in T cell lymphoma

Researchers

Presenter

  • D. Murray

Principal Investigators

  • S. Eldershaw

  • H. Pearce

  • C. Yau

  • J. Scarisbrick

  • P. Moss

Medical Centers

  • Clinical Haematology, University Hospitals Coventry & Warwickshire, Coventry

  • Institute of Immunology and Immunotherapy,

  • Centre for Computational Biology, University of Birmingham

  • University Hospitals Birmingham, Birmingham, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Mycosis fungoides

  • T-cell lymphoma

  • Lymphomas

  • Solid malignancies

Biomarkers

  • T-cell receptor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved